Western Companies Moderna announced topline results from a Phase 3 pivotal trial evaluating mRNA-1647, an investigational cytomegalovirus (CMV) vaccine. The study did not meet its primary efficacy endpoint of preventing...
Tag - BioNTech
Copyright © 2009-2026 Global Health Press Pte Ltd. Reg. No. 200921795N All Rights Reserved.
Subject to Creative Commons Licence (cc).